Zidolam N Tablets

Zidolam N Tablet

*To be consumed as directed by physician.

Therapies:

Anti Virals

Composition:

Lamivudine (150 mg) + Zidovudine (300 mg) + Nevirapine (200 mg)

About Zidolam N Tablet

Zidolam N Tablets is a fixed-dose combination antiretroviral medicine containing Lamivudine 150 mg, Zidovudine 300 mg, and Nevirapine 200 mg. It combines two nucleoside reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV-1 infection. These medicines work together by blocking the reverse transcriptase enzyme required for HIV replication, helping reduce the viral load, improve immune function by increasing CD4 cell counts, and slow the progression of HIV disease. Zidolam N is used as part of long-term antiretroviral therapy (ART) to help reduce the risk of HIV-related complications. It does not cure HIV/AIDS and does not eliminate the risk of transmitting HIV to others.

Zidolam N Tablet

*To be consumed as directed by physician.


Usage Instructions

  • Take Zidolam N Tablets exactly as prescribed by your doctor, with or without food, preferably at the same time every day.
  • Do not skip doses or stop treatment without medical advice, as missed doses may reduce treatment effectiveness and increase the risk of developing drug-resistant HIV.
  • Complete the prescribed treatment regimen and attend regular follow-up appointments.
  • Your doctor may recommend routine monitoring of blood counts, kidney function, liver function, and overall health throughout therapy.
  • Zidolam N should always be used as directed by your HIV specialist.

  • Benefits and Use

  • Zidolam N Tablets helps control HIV-1 infection by suppressing viral replication and lowering the amount of virus in the body.
  • The combination of Lamivudine, Zidovudine, and Nevirapine works through complementary mechanisms to improve treatment effectiveness, helping preserve immune function by increasing CD4 cell counts.
  • Regular use as part of combination antiretroviral therapy reduces the risk of opportunistic infections, delays disease progression, improves quality of life, and supports long-term HIV management.
  • It is intended for the treatment of HIV infection and is not a cure for HIV/AIDS.

  • Safety Information

  • Pregnancy:
  • The safety of Zidolam N Tablets during pregnancy has not been fully established. Use only if prescribed by your doctor after assessing the potential benefits and risks.
  • Breastfeeding:
  • Breastfeeding is generally not recommended in women with HIV due to the risk of HIV transmission to the infant. Follow your doctor's advice regarding breastfeeding while on treatment.
  • Alcohol:
  • Avoid alcohol during therapy, as it may increase the risk of liver-related side effects.
  • Kidney Disorders:
  • Use with caution in patients with kidney disease, as dose adjustment and regular monitoring may be required.
  • Liver Disorders:
  • Use cautiously in patients with liver disease. Liver function tests should be monitored regularly, and medical attention should be sought immediately if symptoms such as yellowing of the skin or eyes, dark urine, severe abdominal pain, or loss of appetite occur.
  • Driving:
  • The medicine may cause dizziness or other symptoms that affect concentration; avoid driving or operating machinery if affected.

  • Ingredients

    Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg

    How to Use

  • Swallow one Zidolam N Tablets whole with water, with or without food, exactly as directed by your physician.
  • Do not crush, chew, or break the tablets.
  • Take it consistently at the same time every day to maintain effective drug levels and maximize treatment success.

  • Storage Information

  • Store below 30°C in a cool, dry place, protected from moisture and direct sunlight.
  • Keep the tablets in the original container with the lid tightly closed.
  • Keep out of reach of children.
  • Do not use after the expiry date printed on the pack.